Rostami et al., 2021 - Google Patents
The ZnFe 2 O 4@ mZnO–N/RGO nano-composite as a carrier and an intelligent releaser drug with dual pH-and ultrasound-triggered controlRostami et al., 2021
- Document ID
- 3167730984299166592
- Author
- Rostami M
- Nasab A
- Fasihi-Ramandi M
- Badiei A
- Rahimi-Nasrabadi M
- Ahmadi F
- Publication year
- Publication venue
- New Journal of Chemistry
External Links
Snippet
In this paper, zinc ferrite@ meso-porous (abbreviated as m) zinc oxide–nitrogen doped reduced graphene oxide (ZnFe2O4@ mZnO–N/RGO) and zinc ferrite@ mZnO–reduced graphene oxide (ZnFe2O4@ mZnO–RGO) as dual ultrasound (US) and pH-sensitive nano …
- 239000003814 drug 0 title abstract description 40
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rostami et al. | The ZnFe 2 O 4@ mZnO–N/RGO nano-composite as a carrier and an intelligent releaser drug with dual pH-and ultrasound-triggered control | |
Cheraghi et al. | Effect of lemon juice on microstructure, phase changes, and magnetic performance of CoFe2O4 nanoparticles and their use on release of anti-cancer drugs | |
Wang et al. | Development of multifunctional cobalt ferrite/graphene oxide nanocomposites for magnetic resonance imaging and controlled drug delivery | |
Wang et al. | Magnetic iron oxide–fluorescent carbon dots integrated nanoparticles for dual-modal imaging, near-infrared light-responsive drug carrier and photothermal therapy | |
Wang et al. | Controlled synthesis of L-cysteine coated cobalt ferrite nanoparticles for drug delivery | |
Justin et al. | Photoluminescent and superparamagnetic reduced graphene oxide–iron oxide quantum dots for dual-modality imaging, drug delivery and photothermal therapy | |
Taboada et al. | Supercritical‐fluid‐assisted one‐pot synthesis of biocompatible core (γ‐Fe2O3)/shell (SiO2) nanoparticles as high relaxivity T2‐contrast agents for magnetic resonance imaging | |
Wang et al. | Multifunctional PEG encapsulated Fe 3 O 4@ silver hybrid nanoparticles: antibacterial activity, cell imaging and combined photothermo/chemo-therapy | |
Dong et al. | Highly porous, water‐soluble, superparamagnetic, and biocompatible magnetite nanocrystal clusters for targeted drug delivery | |
Hafezi et al. | Cur-loaded ZnFe2O4@ mZnO@ N-GQDs biocompatible nano-carriers for smart and controlled targeted drug delivery with pH-triggered and ultrasound irradiation | |
Liu et al. | Glucose-reduced graphene oxide with excellent biocompatibility and photothermal efficiency as well as drug loading | |
Anirudhan et al. | Synthesis, characterization, cellular uptake and cytotoxicity of a multi-functional magnetic nanocomposite for the targeted delivery and controlled release of doxorubicin to cancer cells | |
Moorthy et al. | Fucoidan-coated core–shell magnetic mesoporous silica nanoparticles for chemotherapy and magnetic hyperthermia-based thermal therapy applications | |
Mao et al. | One-step hydrothermal synthesis of Fe 3 O 4@ C nanoparticles with great performance in biomedicine | |
Sanpo et al. | Sol-gel synthesized copper-substituted cobalt ferrite nanoparticles for biomedical applications | |
Jadhav et al. | PVA and PEG functionalised LSMO nanoparticles for magnetic fluid hyperthermia application | |
Manohar et al. | Zn-doped MnFe2O4 nanoparticles for magnetic hyperthermia and their cytotoxicity study in normal and cancer cell lines | |
Ali et al. | Graphene oxide/zinc ferrite nanocomposite loaded with doxorubicin as a potential theranostic mediu in cancer therapy and magnetic resonance imaging | |
Wang et al. | β-Cyclodextrin modified graphene oxide–magnetic nanocomposite for targeted delivery and pH-sensitive release of stereoisomeric anti-cancer drugs | |
Matiyani et al. | Polymer grafted magnetic graphene oxide as a potential nanocarrier for pH-responsive delivery of sparingly soluble quercetin against breast cancer cells | |
Nam et al. | Physical characterization and heating efficacy of chitosan-coated cobalt ferrite nanoparticles for hyperthermia application | |
Karunamoorthi et al. | Fabrication of a novel biocompatible magnetic biomaterial with hyperthermia potential | |
Dehghani et al. | Magnetic graphite-ODA@ CoFe2O4: attempting to produce and characterize the development of an innovative nanocomposite to investigate its antimicrobial properties | |
Chen et al. | Magnetic thermosensitive core/shell microspheres: Synthesis, characterization and performance in hyperthermia and drug delivery | |
Chen et al. | Thermo-sensitively and magnetically ordered mesoporous carbon nanospheres for targeted controlled drug release and hyperthermia application |